1. Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston;
2. Department of Bone Marrow Transplantation, University of Minnesota, Minneapolis;
3. Department of Population Health, Medical College of Wisconsin, Milwaukee;
4. Department of Oncology, The Johns Hopkins University, Baltimore, MD;
5. The EMMES Corporation, Rockville, MD;
6. Transfusion Medicine and Cellular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health/Department of Health and Human Services, Bethesda, MD;
7. Division of Neoplastic Diseases and Related Disorders, Department of Medicine, Center for International Blood and Marrow Transplant Research (CIBMTR) Medical College of Wisconsin, Milwaukee;
8. Division of Hematology/Oncology, University of Pennsylvania, Philadelphia;
9. Department of Medical Oncology/Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA;
10. School of Medicine, Oregon Health and Science University, Portland;
11. Department of Medicine, University of Florida Shands Cancer Center, Gainesville;
12. Division of Neoplastic Diseases and Related Disorders, Department of Medicine, and CIBMTR, Froedtert and The Medical College of Wisconsin, Milwaukee; and
13. Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor